Dr. Baker is the inventor of the platform technology, founder of NanoBio and an internationally recognized expert in immunology and nanotechnology. Dr. Baker invented the NanoStat technology at the University of Michigan, where he is the Ruth Dow Doan Professor of Medicine and Head of Allergy and Immunology at the Medical School. As the Director of the University of Michigan Nanotechnology Institute, Dr. Baker leads a multidisciplinary team of 30 scientists focused on the use of nanotechnology in biomedical applications. He is one of three editors of the National Nanotechnology Initiative’s Research Directives, and a member of the Nanotechnology for Medicine and Biology study section at National Institutes of Health (“NIH”). Dr. Baker is a board-certified internist, allergist and immunologist, a member of American Board of Allergy and Immunology and a Fellow of the American College of Physicians. He is also a Fellow of the American Academy for the Advancement of Science.
As viral pandemics and drug resistant bacteria become more common, it is imperative that the pharmaceutical industry increases its efforts to develop truly revolutionary treatments to combat infectious diseases. One area... Read more »
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Sponsored · Video
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
MedpaceSponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.